Usefulness of biochemical markers of bone turnover in assessing response to the treatment of paget’s disease

This publication has 20 references indexed in Scilit:

• Components of biological variation of biochemical markers of bone turnover in Paget’s bone disease
  Bone, 2000
• Monitoring Alendronate Therapy for Osteoporosis
  Journal of Bone and Mineral Research, 1999
• Measurement of urinary excretion of nonisomerized and ?-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's disease
  Arthritis & Rheumatism, 1998
• Decreased β-Isomerization of the C-Terminal Telopeptide of Type I Collagen α1 Chain in Paget's Disease of Bone
  Journal of Bone and Mineral Research, 1997
• Measurement of Bone Degradation Products in Serum Using Antibodies Reactive with an Isomerized Form of an 8 Amino Acid Sequence of the C-Telopeptide of Type I Collagen
  Journal of Bone and Mineral Research, 1997
• Relationship between biochemical markers of bone turnover and bone scintigraphic indices in assessment of Paget's disease activity
  Arthritis & Rheumatism, 1997
• The Management of Paget's Disease of Bone
  New England Journal of Medicine, 1997
• Adverse Effects of Bisphosphonates
  Drug Safety, 1996
• Rationale for the use of alendronate in osteoporosis
  Osteoporosis International, 1995
• Generation and Application of Data on Biological Variation in Clinical Chemistry
  Critical Reviews in Clinical Laboratory Sciences, 1989